A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2002
11/14/2002	US20020169112 Antibiotics combined with antioxidants to reduce oxidative stresses; improves host cell resistance to oxidative stress while reducing mycoplasma infection levels; methods of HIV therapy
11/14/2002	US20020169110 Diagnosis of metastatic cancer by the mts-1 gene
11/14/2002	US20020169109 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
11/14/2002	US20020169108 Identifying compounds capable of inhibiting fibronectin-mediated processes, by determining whether a candidate compound binds to a fibronectin Type III polypeptide; administering human uteroglobin
11/14/2002	US20020169106 Administering an OB-cadherin CAR (cell adhesion recognition) sequence
11/14/2002	US20020169105 Use of active enamel substances as wound healing, anti-bacterial and/or anti-inflammatory agents
11/14/2002	US20020169104 Novel ectoparasite saliva proteins and apparatus to collect such proteins
11/14/2002	US20020169102 Intranasal delivery of agents for regulating development of implanted cells in the CNS
11/14/2002	US20020168761 Cell adhesion modulator for use in the treatment of nervous system disorders
11/14/2002	US20020168754 Nucleotide sequences coding polypeptides for use in the treatment of gastric, testicular, retinal, nervous system and immunological disorders
11/14/2002	US20020168753 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases
11/14/2002	US20020168752 Polypeptide for use in the treatment and prevention of cancer
11/14/2002	US20020168749 Nucleotide sequences coding polypeptide for use in the treatment and prevention of wounds, angiogenesis, restenosis, atherosclerosis, inflammation, nervous system disorders and cancer
11/14/2002	US20020168748 Polypeptide for use in the diagnosis, prevention and treatment of fungal infections
11/14/2002	US20020168742 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disorders
11/14/2002	US20020168741 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/14/2002	US20020168740 Kinase for use in the treatment of inflammation, viral infection, cancer, sepsis, psoriasis and restenosis
11/14/2002	US20020168739 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of vascular system disorders
11/14/2002	US20020168736 Nucleotide sequences coding protein for use in the treatment of immunological disorders
11/14/2002	US20020168729 Human endokine alpha and methods of use
11/14/2002	US20020168722 Adjusted fibrinogen for use in the treatment blood clotting disorders
11/14/2002	US20020168721 TSG-like gene
11/14/2002	US20020168719 Nucleotide sequences coding proteins for use in the treatment autoimmune and immunological diseases
11/14/2002	US20020168717 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of prostate cancer
11/14/2002	US20020168716 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of tumors, immunological, autoimmune, skin, viral, bone, nervous system and inflammatory disorders
11/14/2002	US20020168715 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/14/2002	US20020168712 Molecules designated LDCAM
11/14/2002	US20020168711 Nucleic acids, proteins, and antibodies
11/14/2002	US20020168710 Anticancer agents; cardiovascular disorders; anticholesterol agents
11/14/2002	US20020168708 Nucleotide sequences coding polypeptide for use in the treatment of parkinson's, chronic obstructive airways, irritable bowel syndrome, muscle and urogenital disorders
11/14/2002	US20020168690 Peptide for use in the treatment of arthritis
11/14/2002	US20020168675 Nucleotide sequences for use in the diagnosis and treatment of psychological disorders
11/14/2002	US20020168674 Amplifying and isolating preferential nucleotide sequences; obtain preferential nucleotide sequence library, incubate with primers, amplify nucleotide sequences, digest, recover preferential nucleotide sequences
11/14/2002	US20020168672 Nucleotide sequences coding proteins for use in the treatment of tumors
11/14/2002	US20020168668 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of neovascularization, cardiovascular, endothelial, kidney, lung, nervous system, pain and metabolic disorders
11/14/2002	US20020168647 Compositions and methods for the therapy and diagnosis of head and neck cancer
11/14/2002	US20020168637 Polypeptide
11/14/2002	US20020168634 Detecting genes associated with cell propagation; generate library of preferential cell, incubate with grid, mutagenize, propagate, harvest, extract and isolate nucleotide sequences, incubate with probes, detect pattern, compare to control
11/14/2002	US20020168631 Random gene unidirectional antisense library
11/14/2002	US20020168628 Variant of LAV viruses
11/14/2002	US20020168627 Polypeptide for use in the treatment and prevention of viral diseases
11/14/2002	US20020168415 Biocompatible; culture product; anticancer agents
11/14/2002	US20020168414 Rapid dehydration of proteins
11/14/2002	US20020168411 Spill resistant pharmaceutical system
11/14/2002	US20020168410 Modulated release from biocompatible polymers
11/14/2002	US20020168406 Gel overcoated with polylysine
11/14/2002	US20020168392 Antimicrobial proteins
11/14/2002	US20020168382 Inducing immunology response
11/14/2002	US20020168381 Mixture of bone protein and ethylene oxide-propylene oxide copolymer; in situ administering
11/14/2002	US20020168380 Moderating immunology response
11/14/2002	US20020168379 Veterinary medicine; swine respiratory system disorders
11/14/2002	US20020168378 Autoimmune disease; anticancer agents
11/14/2002	US20020168376 Plant extracts; sensitization of an animal; screening
11/14/2002	US20020168374 Hla binding peptides and their uses
11/14/2002	US20020168373 House dust mite allergen, Der f VII, and uses therefor
11/14/2002	US20020168367 Novel immunoadhesins for treating and preventing viral and bacterial diseases
11/14/2002	US20020168366 Administering a binding agent capable of binding platelets binding platelets to the binding agent to form captured platelets, inducing activation of the captured platelets and forming a thrombus, which provides therapeutic benefit
11/14/2002	US20020168365 Method for modulating granzyme B uptake and for identifying modulators thereof
11/14/2002	US20020168364 Methods and compositions for modulating tumor growth
11/14/2002	US20020168363 Integrin/adhesion antagonists
11/14/2002	US20020168362 Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
11/14/2002	US20020168361 An isolated protein comprising a soluble CD97 alpha subunit, and soluble subunit is selected from the group alpha 1, alpha 2, and alpha 3, originate as proprotein with beta subunit
11/14/2002	US20020168359 Human tumor necrosis factor receptor TR9
11/14/2002	US20020168357 Administering to a mammal an antibody capable of binding native tissue factor, and linked covalently to a cell antigen or an effector molecule to provide complement fixing ability and antibody dependent cell mediated cytotoxicity
11/14/2002	US20020168356 An antibody capable of binding a PF4AR (platelet factor 4 superfamily member) polypeptide and the polypeptide is an interleukin-8 receptor; antiinflammatory agent
11/14/2002	US20020168354 psiepsilonRack peptide composition and method for protection against tissue damage due to ischemia
11/14/2002	US20020168353 Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof
11/14/2002	US20020168352 A C1 esterase inhibitor (C1-INH) for preventing or delaying hyperacute and/or acute rejection of xenotransplants in mammals
11/14/2002	US20020168350 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells
11/14/2002	US20020168348 Prolonging the acceptance of a graft by administering a short course of an immunosuppressant
11/14/2002	US20020168347 Monocyte derived cells, in a purified form, presenting antigenic epitopes on their membranes after interioriztion and processing of an antigen-antibody complex, such epitope corresponding to proteolytic degradation product of antigen
11/14/2002	US20020168344 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
11/14/2002	US20020168340 For inhibiting and treating HIV-1 and HIV-2 infections
11/14/2002	US20020168339 Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same
11/14/2002	US20020168338 Compositions and methods for delivery of agents for neuronal regeneration and survival
11/14/2002	US20020168337 Sustained-release preparation
11/14/2002	US20020168323 Optimization of the molecular properties and formulation of proteins delivered by inhalation
11/14/2002	CA2483658A1 Bont/e or snap-25e for treating botulinum toxin a or c1 poisoning and inhibiting muscle contraction
11/14/2002	CA2452245A1 Recombinant fusion proteins and the trimers thereof
11/14/2002	CA2449166A1 Combination therapy using anti-egfr antibodies and anti-hormonal agents
11/14/2002	CA2447470A1 Peptide deformylase activated prodrugs
11/14/2002	CA2447360A1 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
11/14/2002	CA2446946A1 Gene transfer of angiogenic factor for skin disease
11/14/2002	CA2446838A1 Novel mutation
11/14/2002	CA2446810A1 Epidermal growth factor receptorantisense oligonucleotides
11/14/2002	CA2446788A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	CA2446666A1 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
11/14/2002	CA2446640A1 .beta.-amyloid peptide-binding proteins and polynucleotides encoding the same
11/14/2002	CA2446458A1 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	CA2446437A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	CA2446394A1 Insulinotropic peptide derivatives
11/14/2002	CA2446322A1 Anti-microbial peptides and compositions
11/14/2002	CA2446204A1 Anti-virus agent
11/14/2002	CA2446087A1 Recombinant tumor specific antibody and use thereof
11/14/2002	CA2445989A1 Colon cancer antigen panel
11/14/2002	CA2445982A1 Sperm-specific cation channel, and uses therefor
11/14/2002	CA2445944A1 Method of preventing type 2 diabetes with aerosolized insulin
11/14/2002	CA2445679A1 Benzazepinone alpha v integrin receptor antagonists
11/14/2002	CA2445271A1 Use of castanospermine esters to treat flaviviridae-related diseases
11/14/2002	CA2445065A1 Trimethyl lock based tetrapartate prodrugs

1 ... 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 ... 3163